Arvinas, Inc. filed a Form 8-K with the SEC on November 3, 2026, announcing its financial results for the quarter ended September 30, 2026, and disclosing an updated corporate presentation under Regulation FD.

Key Highlights

  • Quarterly results announced: Arvinas disclosed financial results for the quarter ended September 30, 2026, according to the filing.
  • Corporate update provided: The company stated it provided a corporate update alongside the financial results announcement on November 3, 2026.
  • Updated presentation filed: The company updated its corporate presentation, furnished as Exhibit 99.2, and noted it would be posted on its investor relations website.
  • Press release attached: A press release issued on November 3, 2026, containing the full financial results text, was furnished as Exhibit 99.1 to the filing.
  • Signed by CFO: The filing was signed by Andrew Saik, Chief Financial Officer of Arvinas, Inc.

Arvinas Furnishes Q3 2026 Earnings Announcement and Corporate Presentation

Arvinas, Inc. (NASDAQ:ARVN), a Delaware-incorporated biopharmaceutical company headquartered at 395 Winchester Ave., New Haven, Connecticut, filed a current report on Form 8-K on November 3, 2026. The filing covered two disclosure items: Item 2.02, relating to results of operations and financial condition for the quarter ended September 30, 2026, and Item 7.01, relating to Regulation FD disclosure of an updated corporate presentation.

Under Item 2.02, the company disclosed that on November 3, 2026, it announced its financial results for the quarter ended September 30, 2026, and provided a corporate update. The full text of the results was furnished as Exhibit 99.1, a press release issued by the registrant on November 3, 2026. The filing noted that the information in Item 2.02 "shall not be deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934," meaning it is furnished rather than filed and is not subject to the liabilities of that section unless expressly incorporated by reference.

Under Item 7.01, the company disclosed that it updated its corporate presentation on November 3, 2026. According to the filing, the presentation would be posted on the Events and Presentations page of the Investors and Media section of the company's website. The presentation was also attached as Exhibit 99.2, dated November 2026, and incorporated by reference into Item 7.01. Similar to Item 2.02, the information in Item 7.01 is furnished and not deemed filed under Section 18 of the Exchange Act. The filing was signed by Andrew Saik in his capacity as Chief Financial Officer.

What Was Disclosed

Arvinas filed an 8-K on November 3, 2026, furnishing its Q3 2026 financial results press release as Exhibit 99.1 and an updated corporate presentation as Exhibit 99.2, with both items furnished rather than filed under the Exchange Act.